Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Attorney Spotlight: Mark Manner

August 4, 2017
Mark Manner spotlight

Tell us about your practice.

I spend most of my time with corporate boards, executives and significant shareholders helping them manage governance, disclosure and acquisition issues and strategies.

Why did you choose to pursue a career in the legal field?

I was uncertain about whether I wanted to pursue a career in medicine or research chemistry, and decided to spend a year at law school to think more about what I might like to do. I found that I enjoyed the legal method and decided to finish and prepare for a career teaching law. Family ties brought me back to Nashville, and my small firm became very active in the rapidly growing Nashville healthcare community. I found I really enjoyed working with and advising start-up healthcare companies. Being a lawyer is challenging, but it also provides a lot of flexibility, which allowed me to continue to participate in non-legal activities that were important to me.

Your lifelong passion with astronomy has led you to work with NASA and various leading academic institutions, what is one of your most exciting/proudest experiences related to your astronomy work?

I have been extremely fortunate to be involved with the inter-university KELT program and participate in the discovery of multiple exoplanets. I think having one of our discoveries featured on the cover of Nature recently was pretty exciting. Having the slightly amused approval of my daughter, a real scientist, is probably the best, however.

In anticipation of the August 21 total solar eclipse that will be visible in the United States, I am answering key questions and providing insights on what to expect during this astronomical event. Check out the firm's special webpage dedicated to the 2017 American Total Solar Eclipse here.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.